Home ›
Entities
› academia
› Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without <i>MYCN</i> Amplification: A Children's Oncology Group (COG) Report
Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without <i>MYCN</i> Amplification: A Children's Oncology Group (COG) Report
Research article (Clinical Cancer Research, 2023) · cited 17× · AI/ML
Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) Report
Summary
Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) Report is a scholarly article[1].
Key Facts
Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) Report's instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without <i>MYCN</i> Amplification: A Children's Oncology Group (COG) Report. Retrieved May 24, 2026, from https://4ort.xyz/entity/impact-of-genomic-and-clinical-factors-on-outcome-of-children-18-months-of-age-with-stage-3-neuroblastoma-with-unfavorab
MLA“Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without <i>MYCN</i> Amplification: A Children's Oncology Group (COG) Report.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/impact-of-genomic-and-clinical-factors-on-outcome-of-children-18-months-of-age-with-stage-3-neuroblastoma-with-unfavorab.
BibTeX@misc{4ortxyz_impact-of-genomic-and-clinical-factors-on-outcome-of-children-18-months-of-age-with-stage-3-neuroblastoma-with-unfavorab_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without <i>MYCN</i> Amplification: A Children's Oncology Group (COG) Report}}, year = {2026}, url = {https://4ort.xyz/entity/impact-of-genomic-and-clinical-factors-on-outcome-of-children-18-months-of-age-with-stage-3-neuroblastoma-with-unfavorab}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without <i>MYCN</i> Amplification: A Children's Oncology Group (COG) Report — https://4ort.xyz/entity/impact-of-genomic-and-clinical-factors-on-outcome-of-children-18-months-of-age-with-stage-3-neuroblastoma-with-unfavorab (retrieved 2026-05-24)
